(NASDAQ: TYRA) Tyra Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 44.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.48%.
Tyra Biosciences's earnings in 2025 is -$111,684,000.On average, 10 Wall Street analysts forecast TYRA's earnings for 2025 to be -$108,062,487, with the lowest TYRA earnings forecast at -$108,270,638, and the highest TYRA earnings forecast at -$108,718,964. On average, 10 Wall Street analysts forecast TYRA's earnings for 2026 to be -$121,875,186, with the lowest TYRA earnings forecast at -$140,699,525, and the highest TYRA earnings forecast at -$103,675,300.
In 2027, TYRA is forecast to generate -$125,621,907 in earnings, with the lowest earnings forecast at -$138,607,339 and the highest earnings forecast at -$103,114,893.